Form 4 · Filed Jul 21, 2026, 10:25 PM UTC
RANI/Rani Therapeutics Holdings, Inc.
Imran Talat — Chief Executive Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
7 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 27, 2026 | F | other | 7,927 | $1 | $5,866 | 434,736 |
| Mar 27, 2026 | F | other | 9,099 | $1 | $7,370 | 442,663 |
| Mar 22, 2026 | F | other | 8,916 | $1 | $10,075 | 451,762 |
| Dec 27, 2025 | F | other | 7,906 | $1 | $11,068 | 460,678 |
| Sep 27, 2025 | F | other | 9,077 | $0 | $4,357 | 468,584 |
| Jun 27, 2025 | F | other | 9,076 | $1 | $4,992 | 477,661 |
| Dec 27, 2024 | S | sell | 8,014 | $1 | $11,300 | 486,737 |
Source: SEC EDGAR raw filing ↗ · Accession 0001869579-26-000006